skip to content
skip to nav
Support Us
For the Press
Corporate Support
amfAR, The Foundation for AIDS Research
Research
Overview
Grants
Countdown to a Cure for AIDS
amfAR Institute for HIV Cure Research
amfAR Research Consortium on HIV Eradication: (ARCHE)
Publications
Videos
Scientific Advisory Committee
Staff
Archive
Policy and Advocacy
Staff
Policy Priorities
Awards
Events
Public Policy Media Highlights
Public Policy Press Releases
Peer-reviewed Publications
Archive
TREAT Asia
TREAT Asia
About TREAT Asia
Research and Treatment
Education and Training
Community Advocacy and Policy
TREAT Asia Publications and Materials
Get Involved
Donate
Corporate Sponsors
Events
Countdown to a Cure
About HIV/AIDS
Basic Facts About HIV/AIDS
Statistics: Worldwide
Statistics: United States
Statistics: Women and HIV AIDS
Young People and HIV AIDS
A Practical Guide to Getting Tested for HIV
Links to Other HIV Resources
About amfAR
Our Work
History
Leadership
Key Accomplishments
Publications
Public Service Ad Campaigns
GMT Initiative
Shop
For the Press
print
|
email
|
share
Staff
Policy Priorities
Awards
Events
Public Policy Media Highlights
Public Policy Press Releases
Peer-reviewed Publications
Archive
Policy and Advocacy Archive
Articles
2021
Biden Releases Updated National HIV/AIDS Strategy
Stark Inequities Continue to Undermine U.S. HIV Response
amfAR’s Greg Millett Presents on 40th Anniversary of HIV/AIDS
U.S. Sees Progress on HIV, Room for Improvement
A Neglected Population: Transgender Inclusion in National HIV Plans
Getting PrEP to Key Populations Is Critical to Global Fight Against HIV
People Living with HIV Should Be Prioritized for Coronavirus Vaccine
FDA Approves Long-Acting Injectable to Treat HIV
2020
amfAR’s Greg Millett Presents at Smithsonian World AIDS Day Event
amfAR Study Wins Elsevier Atlas Award
Deaths Related to HIV Drop by Half in U.S.
Long-Acting Injectable Prevents HIV in Women
PEPFAR in the Age of COVID-19 -- The Need for Supplemental Funding
PEPFAR in the Age of COVID-19: The Need for Supplemental Funding
ISSUE BRIEF: Violence Crisis Services During Lockdown - PDF
amfAR Study Shows How White Counties Have Lower Rates of COVID-19 and HIV
Factors Linked to Structural Racism Put Latino Communities at Risk for COVID-19, New Study Says
Global Anti-HIV Drug Supplies Running Low
International AIDS Conference Goes Virtual
Long-Acting Antiretroviral Blocks HIV
CDC: Increased Action Needed to End HIV Epidemic in U.S.
amfAR Study Shows Disproportionate Impact of COVID-19 on Black Americans
Context Matters - Health Insurance Coverage Is Fundamental to Ending the HIV Epidemic
Ending the HIV/AIDS Pandemic: A Roadmap
Ending
amfAR Policy Data Used in Congressional Briefing
Infographic - Context Matters
2019
Issue Brief: The Expanded Mexico City Policy - Implications for the Global Fund
Data Watch: Data Accessibility from Global Funders of HIV, TB, and Malaria Programming
Context Matters - Ending the HIV Epidemic Among Latinx
Infographic - Ending the HIV Epidemic Database
amfAR Launches New Ending the HIV Epidemic Database
Researchers Report Findings at International Conference on HIV Science
A Global Response to HIV Requires the Global Fund (Infographics)
How the Global Fund Improves PEPFAR Investments
amfAR Policy Data Used by Congress
A Global Response to HIV Requires the Global Fund
Expanding Access to Pre-Exposure Prophylaxis (PrEP) for Adolescents and Young Adults
amfAR Statement on Trump Administration Budget Proposal
New HIV Testing Strategies in PEPFAR COP19: Rollout and Human Rights Concerns
Issue Brief - Title X, the Domestic Gag Rule, and the HIV Response
INFOGRAPHIC: How Expanded Mexico City Policy Is Disrupting Global HIV Programs
amfAR’s Statement on President Trump’s Plan to End HIV Transmissions in the US
The Effect of the Expanded Mexico City Policy on HIV/AIDS Programming: Evidence from the PEPFAR Implementing Partners Survey
amfAR’s Medication-Assisted Treatment Analysis Featured in New York Times
2018
amfAR Opposes Efforts to Halt Use of Fetal Tissue in HIV Cure Research
amfAR Launches Important New PEPFAR Advocacy Resource
amfAR Reports Negative Effects of Expanded Mexico City Policy on PEPFAR Partners
amfAR Analysis Examines Potential Avenues for Increasing Efficiencies in Global HIV/AIDS Investments
amfAR Opposes Latest Assault on Transgender Rights
New Study Suggests Most Substance Abuse Facilities Don’t Test for HIV
Impact of the Expanded Mexico City Policy on PEPFAR
UNAIDS Warns that Progress on HIV Is Slowing
A “Dangerous Complacency” Is Threatening the Global HIV Response
PERSPECTIVES: What Should be Done to Strengthen Youth-led HIV Advocacy in the Asia-Pacific Region?
When Size Matters: How Social Media Can Help Determine Key Population Size
Amsterdam to Host 22nd International AIDS Conference
Long-Acting HIV Treatment and Prevention Are Coming
long-acting-ARV-chart
DC-2018-FDA-Consolidated-071118v111-web_pdf
long-acting-ARV-market
DC-2018-Assessing-the-Plyer-Landscape-071118v401-web_pdf
Toward an Effective Strategy to Combat HIV, Hepatitis C and the Opioid Epidemic: Recommendations for Policy Makers
amfAR Study Assesses Impact of Medicaid Expansion on the Opioid Epidemic
Infographic - Lives on the Line: The Human Impact of Proposed Cuts to Global HIV Funding
Global Health Policy Gets Short Shrift from State Department
Living Happily, Healthily: A Conversation with HIV Trans Activist Tori Cooper
amfAR Report Highlights Huge Gaps in Access to Opioid Addiction Treatment
amfAR’s Greg Millett Honored by HIV Plus Magazine
2017
Big Data and the Opioid Epidemic
amfAR Featured in Washington Post Live's "Pathways to Progress: Combating the HIV/AIDS Epidemic"
Syringe Services Programs: The Facts
A Modest Increase in U.S. Investment to Fight HIV/AIDS in sub-Saharan Africa Could Prevent 22 Million New HIV Infections by 2032
Syringe Services Programs and the Opioid Epidemic
Issue Brief: Impact of Mexico City Policy on PEPFAR
New amfAR Analysis Highlights Opportunities To Improve Gender Responsiveness Of National HIV/AIDS Strategic Plans
amfAR to Figure Prominently at International HIV Science Conference
Opioid Addiction - the Next AIDS Epidemic?
Issue Brief: The Case for Supervised Consumption Services
New York Times Magazine Explores ‘Hidden HIV Epidemic’
Derailing Progress: The Human Impact of the U.S. FY2018 Global Health Budget
FY2017 U.S. Global AIDS Budget: The Human Impact
At amfAR Capitol Hill Conference, Government and Health Leaders Urge Continued Investments in HIV/AIDS Programs To End Epidemic
Straight with HIV: An Interview with Joshua Middleton
For Gay Men, the Battle Against HIV Is Far From Over
Defending a Woman’s Right to Live Without HIV
Amid Signs of Progress, African Americans Remain Most Affected by HIV/AIDS
How Cures Can Fail
2016
UNAIDS Reports Record Number on Antiretroviral Therapy - Warns Young Women Still at High Risk
TAG/amfAR Publication Proposes an Integrated HIV Prevention Continuum
amfAR Publishes Recommendations for Health Plans and Health Care Purchasers to Support Efforts to Curb the HIV Epidemic in the U.S.
Lifting All Boats: The Broad Benefits of Increased Investments in HIV/AIDS Research
The World Without PEPFAR
Curbing the HIV Epidemic by Supporting Effective Engagement in HIV Care
Is PEPFAR Funding for Key Populations Aligned with the Epidemiologic Burden?
The amfAR Country/Regional Operational Plan Database
Following the Money to Key Populations, National Priorities, and Evidence-Based Budgeting
Durban Hosts 21st International AIDS Conference
Kenneth Cole Appointed UNAIDS Goodwill Ambassador
New Report Reveals Uneven Progress on Global HIV/AIDS
New Analyses Show Where to Focus HIV Prevention and Care Efforts
A Step Forward for HIV Prevention
amfAR Calls for Increase in HIV/AIDS Research Funding at National Institutes of Health
Infographic: Small Increase, Big Impact: Investing in HIV/AIDS Research Could Fund the World’s Next Medical Breakthrough
Sustaining Global HIV Programs and the Transition to Greater Country Ownership
Congress Eases Restrictions on Funding for Syringe Exchange
2015
Plugging the Implementation Gaps
Special Report: Harm Reduction and the Global HIV Epidemic
amfAR Donors to Match Funds Raised on CrowdRise by Celebrity Riders in the 6th Kiehl's LifeRide for amfAR
White House Releases Updated National HIV/AIDS Strategy
New amfAR Report Highlights Priority Actions to Help States Achieve National HIV/AIDS Strategy Goals
Bolstering State Efforts to Implement the National HIV/AIDS Strategy: Key indicators and Recommendations for Policymakers and Community Stakeholders
Hepatitis C in the United States: A Hidden and Growing Epidemic
amfAR Launches PEPFAR Country/Regional Operational Plan Database
New amfAR Report Warns of Trade Agreement’s Potentially Damaging Effects on Global Public Health
Issue Brief: Trans-Pacific Partnership: Curbing Access to Medicines Now and in the Future (May 2015)
Lack of Syringe Services Programs Adds Up to Big Costs (Infographic)
HuffPo Live: H.I.V. Cases Lead Indiana To Extend Needle Exchanges
Infographic: Investing for Impact: Accelerating the U.S. and Global AIDS Response in FY2016
Why Congress Should Rethink Syringe Issue (CNN Opinion Piece))
Surge of HIV Cases Among Drug Users in Indiana Underscores Value of Syringe Services Programs
Issue Brief: Preventing HIV and Hepatitis C Among People Who Inject Drugs: Public Funding for Syringe Services Programs Makes the Difference
Women and HIV/AIDS: Fast Tracking the U.S. and Global Response
HIV/AIDS and Key Populations in West and Central Africa
Women and HIV/AIDS Fast-Tracking the U.S. and Global Response
Women and HIV/AIDS: Fast-Tracking the U.S. and Global Response RSVP Form
amfAR Report Examines Controversial Pricing of Hepatitis C Treatment(1)
amfAR Report Examines Controversial Pricing of Hepatitis C Treatment
Time to close HIV's racial disparities
amfAR Report Examines Heavy Impact of HIV/AIDS on Black Gay Men in the United States
amfAR Welcomes Continued AIDS Funding in President's Budget Proposal, Including Important Increase for PEPFAR and HIV/AIDS Research
Mario Cuomo: A Forceful and Compassionate Advocate
2014
Trans Populations and HIV: Time to End the Neglect PDF 4-2014
amfAR Welcomes New Federal Investments to Fight Global and Domestic HIV/AIDS Epidemic
New Study Shows Dire Consequences from Elevated HIV Cases among Black Gay Men in the U.S.
FY2015 U.S. Global AIDS Budget Plan: The Human Impact (Infographic)
CDC Releases New Data on Trends in the U.S. HIV Epidemic
AIDS to Ebola: Moving From Peril to Progress
New Report Finds Missing and Incomplete Data Imperils the Global HIV/AIDS Response
amfAR Praises Governor Andrew Cuomo’s Plan to End AIDS in New York
A World Without AIDS for American Women
HIV Testing: The Key to Ending AIDS in America?
Policy and Research Leaders Headline amfAR Capitol Hill Summit
amfAR Statement on Ugandan HIV Prevention and Control Act
amfAR Capitol Hill Briefing Convenes Leading Global Health Experts to Chart a Roadmap for Ending the HIV/AIDS Epidemic Worldwide
amfAR Denounces Raid on the Makerere University Walter Reed Project by Ugandan Authorities
Infographic: Medicaid Expansion: An Essential Tool to Fight HIV and Health Disparities
Issue Brief: Trans Populations and HIV: Time to End the Neglect
amfAR Applauds the Selection of Douglas M. Brooks as Director of the Office of National AIDS Policy
Sustaining the Global HIV Response: Innovative Financing Options
America Without HIV/AIDS in Women: A Wish for This National Women and Girls HIV/AIDS Awareness Day
amfAR Warns of Slowdown in Global AIDS Response
2014 amfAR Capitol Hill Conference
Stop the Anti-LGBT Laws in Uganda and Nigeria
amfAR Denounces Passage of Ugandan Anti-Homosexuality Bill
Getting the Job Done
The Investment Case for Global AIDS Funding: Getting Smarter, Showing Results
Don’t Put the Brakes on Ending AIDS
Trends around HIV/AIDS among GMT in Southern Africa
amfAR Hails Nomination of Global Health Leader Dr. Deborah Birx as U.S. Global AIDS Coordinator
2013
How Many Lives Do Your Taxes Save Each Year?
Time to Tip the Scales in Favor of Ending AIDS
Syringe Services Controversy Brews in Western Massachusetts
amfAR Mourns the Loss of Former South African President Nelson Mandela
amfAR Welcomes Clear Signs of Progress on Domestic HIV/AIDS Epidemic
An Open Letter to Incoming PEPFAR Coordinator on Key Populations
Sequestration 2014: Undermining the Response to HIV/AIDS in the U.S.
amfAR Hails Passage of PEPFAR Stewardship and Oversight Act
A World AIDS Day Request to President Obama
Winning the Battle but Losing the War: Prescription Drug Abuse and Syringe Services Programs
amfAR Applauds Passage of the HOPE Act
Syringe Services Programs: Myth vs. Fact
The Impact Of FY14 Budget Sequestration On US-Funded Global Health Programs
An Action Agenda to End AIDS
The National HIV/AIDS Strategy at Three: Time for Recommitment to Ending AIDS in America
Issue Brief: The Costs of Flat Funding for Biomedical Research
amfAR Goes to Capitol Hill to End the Ban on Funding Syringe Exchanges
amfAR Think Tank on Implementation Science for PWID
amfAR Recognizes Anniversary of the National HIV/AIDS Strategy – Welcomes New Administration Initiatives
Capitol Hill Briefing: Where Are We in Ending the AIDS Epidemic?
How much of your U.S. taxes goes toward stopping AIDS, malaria and child mortality?
AIDSVu Updates Its Interactive Maps of HIV in the U.S.
Preventing HIV Among People Who Inject Drugs - Developing an Implementation Science Agenda
amfAR Applauds Supreme Court Decision on Anti-Prostitution Pledge
PEPFAR Turns 10: The Progress and the Promise
If We Want an AIDS-Free Generation, Why Are We Cutting PEPFAR?(1)
amfAR Welcomes Increased AIDS Funding in President’s Budget Proposal, Including Important Increase for Global Fund
FY2014 Budget Plans And Global HIV/AIDS: The Human Impact(2)
If We Want an AIDS-Free Generation, Why Are We Cutting PEPFAR?
Contact Your Legislator To Help End the Ban
PEPFAR Receives Glowing Report, but Funding at Risk
March Update: The Effect of Budget Sequestration on Global Health - Projecting the Human Impact in Fiscal Year 2013
Key points from Think Tank on the Lancet special issue on MSM and HIV
The Effect of Budget Sequestration on Global Health: Projecting the Human Impact in Fiscal Year 2013
The Effect of Budget Sequestration on HIV/AIDS in the United States: Projecting the Human Impact in Fiscal Year 2013
amfAR Calls for Restoration of Federal Support for Syringe Services Programs
The Effect of Budget Sequestration on Global Health: Projecting the Human Impact in Fiscal Year 2013
Global Advocacy Corps Grants Support Analysis and Advocacy at the National Level
Obama - The President Who Ends AIDS
Global Advocacy Corps
Articles
2012
Then They Came For Me…
amfAR Hails Release of AIDS-Free Generation Blueprint
amfAR Welcomes Mark Dybul as New Global Fund Executive Director
HIV Prevention Must Resume Its Place in the Larger LGBT Agenda
Sequestration Will Cut $659 Million from Domestic HIV/AIDS and Viral Hepatitis Programs
September 2012 Update: The Effect of Budget Sequestration on Global Health
New Report Calls for Rethinking Battle Against HIV/AIDS Among Gay Men in U.S.
A Cure for HIV/AIDS: Recent Breakthroughs and New Research Frontiers
Gay Men, MSM Key to Successful HIV/AIDS Response
amfAR Hails Commitments by Secretary Clinton
amfAR and AVAC Launch Global Action Agenda for Ending AIDS
amfAR Supports FDA Approval of Pre-Exposure Prophylaxis (PrEP)
The National HIV/AIDS Strategy at Two: The beginnings of reform, and a glimpse of success
amfAR Applauds Decision by U.S. Supreme Court to Uphold Majority of Health Care Reform Law
The Effect of Budget Sequestration on Global Health: Projecting the Human Impact in Fiscal Year 2013
amfAR Applauds FDA Panel Recommendation on Pre-Exposure Prophylaxis (PrEP), Urges Swift Action on Approval
FDA Hearing on PrEP Set for May 10
amfAR Welcomes Selection of Grant Colfax, M.D., to Lead Office of National AIDS Policy
Why Cutting PEPFAR Is Bad Policy
amfAR Opposes Proposed Cuts to Bilateral Global AIDS Funding
President Obama’s Commitment to an AIDS-Free Generation (and How to Make It Happen)
New Analysis: Failure to Address Pandemic Among Gay Men and Other Men who have Sex with Men (MSM) Imperils Goal of “AIDS-Free Generation”
2011
amfAR Applauds President Obama’s Bold Commitment to Begin to End the AIDS Epidemic at Home and Abroad
amfAR Welcomes Sweeping Obama Administration Policies Designed to Protect Gays and Lesbians Abroad
amfAR Deeply Critical of Re-Imposition of Ban on Federal Funding for Syringe Exchange
amfAR Applauds Remarks on U.S. Global AIDS Leadership from Secretary of State Hillary Clinton
Global Health Cuts in Proposed Debt Deal Would Have Negligible Budget Impact but Cost Thousands of Lives
amfAR Calls for New Paradigm for HIV Prevention Among Gay Men
amfAR Warns of Deadly Human Impact of Proposed Cuts in Global Health Funding
amfAR Commemorates First Anniversary of National HIV AIDS Strategy
amfAR Welcomes NIH-Funded HIV AIDS Cure Initiative
amfAR Applauds Release of PEPFAR Guidance for Preventing HIV Among MSM
Early HIV Treatment Greatly Decreases Transmission Rate to Partners
A Step Forward in Tackling America’s AIDS Epidemic (Now the Work Begins)
amfAR Capitol Hill Briefing Explores New HIV Prevention Technologies, Underscores Importance of Adequate Funding and Targeting High-Risk Groups
Devastating Impact Projected from Global Health Funding Cuts in House Continuing Resolution
Lives at Stake: amfAR Analysis Shows Potential Human Impact of Cutting Global Health Funding
amfAR Applauds Commitment to National HIV AIDS Strategy in FY2012 Budget but Is Concerned About Near Flat-Funding of Global AIDS Efforts
2010
Policy Consultation Report: Preventing HIV Among Gay Men in the U.S. (in conjunction with Trust for America's Health) (December 2010)
Public Health Leaders to Obama: AIDS Investments Save Lives, We Need Your Leadership
amfAR Analysis: Potential Impact of Increased Investments in HIV AIDS Programs
Dr. Susan Blumenthal, amfAR Medical Advisor, Honored as a 2010 GQ Rock Star of Science™
amfAR Analysis: Proposed Congressional Budget Cuts Will Severely Undercut U.S. Response to Domestic and Global AIDS Crisis
amfAR’s Chris Collins Honored for National HIV AIDS Strategy Advocacy
How HIV Prevention Has to Change
Letter to Secretary Sebelius on Research and the National Strategy
amfAR Calls Protest Against Speaker Pelosi Unwarranted and Counterproductive
amfAR Applauds President Obama’s National HIV AIDS Strategy
amfAR Signs Vienna Declaration, Advocating for Evidence-Based Drug Policies
amfAR Urges U.S. Government to Lift Blood Donation Ban for Men Who Have Sex with Men
Setting an Agenda for Intermittent PrEP Research
Top NIH Infectious Disease Expert: More Research Could Bring About a “Functional Cure” for HIV AIDS
amfAR VP Chris Collins Receives Positive Leadership Award
U.S. Senate Condemns Ugandan “Anti-Homosexuality Bill”
Rosenfield Fellowships to Support Young Public Health Leaders
amfAR Urges U.S. Congress to Affirm Human Rights Regardless of Sexual Orientation
amfAR Applauds House Passage of Health Reform Bill
amfAR Helps Organize House Hearing on AIDS and Global Health Spending
The Other Healthcare Debate
amfAR Calls for a Reassessment of HIV Prevention Efforts for Men Who Have Sex With Men (MSM) in the U.S.
AIDS Research: A Sound Investment
amfAR Supports Congressional Resolution Condemning Anti-Homosexuality Bill in Uganda
amfAR CEO Frost Named to Presidential Advisory Council on HIV AIDS
amfAR Welcomes Increase in AIDS Research Funding, Calls for Expanded Investments
2009
amfAR Applauds Lifting of Ban on Federal Funding for Syringe Exchange
Syringe Exchange Ban May Be Lifted Soon
Report Urges U.S. Government to Increase Global AIDS Funding
amfAR Welcomes Lifting of U.S. Ban on HIV-Positive Visitors and Immigrants
Video: Chris Collins on amfAR's Policy Priorities
amfAR Supports Presidential Action on Syringe Exchange Programs
President Obama's New $5 Billion Investment: A Welcome Boost for HIV AIDS Research
Join the Discussion: Help Shape the National AIDS Strategy
Syringe Exchange Takes Center Stage in amfAR’s Advocacy Efforts
amfAR Commends Latest Congressional Action Advancing AIDS Prevention
A Crucial Step for Advancing HIV AIDS Prevention
amfAR Commends Congressional Action on Syringe Exchange Programs
amfAR Applauds First Step to Remove Ban on Federal Funding for Syringe Exchange Programs
amfAR Welcomes Steps to Lift Ban on HIV-Positive Visitors
The Challenge and Opportunity of a National AIDS Strategy
amfAR Policy and Medical Advisor Blumenthal Named Health Leader of the Year
Video: Capitol Hill Conference
Chris Collins Joins amfAR as Vice President and Director of Public Policy
amfAR Issues Call to Action at Groundbreaking Capitol Hill Conference
amfAR Disappointed That Syringe-Exchange Ban Not Removed from President’s Proposed Budget
amfAR Endorses Confirmation of Dr. Eric Goosby to Head OGAC
Government Moves to “Act Against AIDS” in the U.S.
Older
Women and HIV: Still Burdened by Stigma
amfAR to Release Survey Results Showing Pervasive HIV Stigma
HIV/AIDS in Correctional Settings: A Congressional Briefing
Stem Cell Move Heralds Hopeful New Era for Biomedical Research and for AIDS
National AIDS Policy Nominee Must Move Swiftly on National AIDS Strategy
amfAR CEO Weighs In on Need for Health Leadership in Washington
President Obama Reverses “Global Gag Rule”
amfAR Voices Support for Obama’s Pick for Top Job at CDC
Top Seven AIDS Policy Issues Facing the New Administration
Poll: If you had an infant son, would you have him circumcised as a preventive measure against HIV? [January 2009]
How Will Obama Fight AIDS?
Can a Pill a Day Prevent HIV?
AIDS: A Stigma Endures
New President, a New Era in HIV/AIDS Policy
Poll: Who should be tested for HIV? [July 2008]
Poll: Which region of the U.S. has the largest number of people living with AIDS? [June 2008]
Poll: Virginity Pledges [November 2007]
Poll: Should the U.S. Welcome People with HIV? [January 2008]
Poll: Should condoms be made available in U.S. prisons and jails? [April 2007]
Poll: Should an HIV-positive woman have a child if she wants to? [May 2008]
Poll: Should a student’s HIV-positive status be reported to his or her school administration? [October 2008]
Poll: Is Oral Sex Safe Sex? [November 2007]
Poll: How much influence does television have on the sexual behaviors of teens? [December 2007]
Women, Sexual Violence, and HIV: an amfAR Monograph
Women, Sexual Health, and HIV/AIDS Initiative
Women and HIV: There Is No Debate
Why is Politics Determining U.S. Health Policy?
WHO Releases New Guidelines Addressing Health Worker Shortages
When “Just Say No” Isn’t Enough - Stopping HIV Infections Among Drug-Using Populations
What's New with the Caucus for Evidence-Based Prevention?
Washington, D.C., To Implement HIV/AIDS Curriculum in Fall 2008
Washington Releases City’s First Statistics on HIV
UNAIDS Revises Global HIV/AIDS Estimates
Thembi’s AIDS Diary
The Employment Non-Discrimination Act (ENDA) Passes in the U.S. House of Representatives
Syringe Exchange Victory Possible in D.C.?
Study Shows Inadequate Retention Rates in Sub-Saharan Africa ART Programs
Senate Holds Hearing on PEPFAR
Senate Committee Holds Hearing on NIH Funding
Senate Bill Seeks to Lift Ban on HIV-Positive Visitors
Report Highlights Failures in Delivery of HIV/AIDS Services for Immigrants Detained by the U.S.
President Bush Signs FY 2008 Omnibus: Bill Mandates Free Access to NIH-Funded Research Findings
Policy Implications of Merck’s Recently Halted HIV Vaccine Trials
New Law Allows Funding for Syringe Exchange Programs in D.C.
House Passes PEPFAR Reauthorization
House Committee Holds Hearing on Abstinence-Only Programs
HIV’s Alarming Impact on Women of Color
HIV Prevention Methods for Women, An Update
HIV in Black America - World AIDS Day Congressional Briefing Focuses on Black Women and Families
Empowerment Through Advocacy: amfAR Interns Take on the Hill
Drug Use Fueling Epidemics in the East
Committee Approves FY2008 Labor, Health and Human Services, Education Spending Bill
China to Ease Travel Restrictions for People Infected with HIV
CDC’s 2006 Routine HIV Testing Guidelines Incompatible with State Laws
California’s 2008–09 Budget Proposal Cuts HIV/AIDS Funding
Bills Aim to Boost Global HIV Prevention Among Women and Youth
Arizona Joins Other States in Rejecting Abstinence-Only Funds
amfAR Submits Testimony to Congressional Subcommittee Hearing on Harm Reduction
amfAR Speaks Out Against Proposed NIH Budget Cuts
amfAR Joins Call For Congress to Review Abstinence-Only Programs
amfAR and Partners Form Caucus for Evidence-Based Prevention
AIDS-Related Deaths in New York City At Record Low
A Quarter of Female Teens in America Infected with Common Sexually Transmitted Infection
Participate
Sign Up for Newsletters
Follow Us on Facebook
Follow Us on Twitter
Follow Us on Instagram
Follow Us on YouTube
Donate via AmazonSmile
Sign Up Today!
Donate Now